Good afternoon :)
Place Order
Add to Watchlist

ANG Lifesciences India Ltd

ANG

ANG Lifesciences India Ltd

ANG
Health CarePharmaceuticals
SmallcapWith a market cap of ₹60 cr, stock is ranked 3,391
Moderate RiskStock is 2.98x as volatile as Nifty
46.510.41% (-0.19)
46.510.41% (-0.19)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹60 cr, stock is ranked 3,391
Moderate RiskStock is 2.98x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹60 cr, stock is ranked 3,391
Moderate RiskStock is 2.98x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-4.090.79
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.906.610.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2021FY 2022FY 2023FY 2024TTM
Total Revenue154.93355.20229.61146.81109.47
Raw Materialssubtract140.12234.65156.08102.79107.40
Power & Fuel Costsubtract6.146.504.15
Employee Costsubtract21.2923.9719.35
Selling & Administrative Expensessubtract18.7015.4912.85
Operating & Other expensessubtract5.623.12-1.39
Depreciation/Amortizationsubtract1.335.889.358.377.33
Interest & Other Itemssubtract3.529.4212.4811.4110.61
Taxes & Other Itemssubtract3.1113.192.89-0.57-1.14
EPS4.7431.11-0.21-7.77-11.28
DPS0.800.000.000.00
Payout ratio0.000.030.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2019

Annual report

PDF

Investor Presentation

Jun 14PDF
FY 2022

Annual report

PDF

Investor Presentation

Oct 26PDF
Sep 6PDF
FY 2023

Annual report

PDF

Investor Presentation

Aug 14PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
ANG Lifesciences India Ltd-5.930.79
Sun Pharmaceutical Industries Ltd45.106.440.75%
Cipla Ltd29.414.520.87%
Torrent Pharmaceuticals Ltd68.5016.550.84%

Price Comparison

Compare ANG with any stock or ETF
Compare ANG with any stock or ETF
ANG
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding70.60%0.00%0.00%0.00%29.40%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateNov 2, 2021

Interim
Interim | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Nov 2, 2021

News & Opinions
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.09 crore in the September 2024 quarter

Net Loss of ANG Lifesciences India reported to Rs 2.09 crore in the quarter ended September 2024 as against net loss of Rs 2.32 crore during the previous quarter ended September 2023. Sales declined 1.14% to Rs 32.88 crore in the quarter ended September 2024 as against Rs 33.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.8833.26 -1 OPM %6.964.99 - PBDT0.45-0.41 LP PBT-1.29-2.63 51 NP-2.09-2.32 10 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
ANG Lifesciences India to conduct board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
ANG Lifesciences India to hold AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
ANG Lifesciences India to convene AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 3.07 crore in the June 2024 quarter

Net loss of ANG Lifesciences India reported to Rs 3.07 crore in the quarter ended June 2024 as against net profit of Rs 1.75 crore during the previous quarter ended June 2023. Sales declined 67.39% to Rs 18.41 crore in the quarter ended June 2024 as against Rs 56.46 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.4156.46 -67 OPM %-9.2311.58 - PBDT-2.514.55 PL PBT-4.142.36 PL NP-3.071.75 PL Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
ANG Lifesciences India to discuss results

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

North Eastern Carrying Corporation Ltd leads losers in ‘B’ group

1 year agoBusiness Standard

Alps Industries Ltd leads losers in ‘B’ group

1 year agoBusiness Standard

ANG Lifesciences India Ltd leads losers in ‘B’ group

1 year agoBusiness Standard

Multibagger pharma stock announces record date for bonus issue

2 years agoLivemint